BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 32395749)

  • 1. Comparison of euploidy rates of blastocysts in women treated with progestins or GnRH antagonist to prevent the luteinizing hormone surge during ovarian stimulation.
    La Marca A; Capuzzo M; Sacchi S; Imbrogno MG; Spinella F; Varricchio MT; Minasi MG; Greco P; Fiorentino F; Greco E
    Hum Reprod; 2020 Jun; 35(6):1325-1331. PubMed ID: 32395749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian response and embryo ploidy following oral micronized progesterone-primed ovarian stimulation versus GnRH antagonist protocol. A prospective study with repeated ovarian stimulation cycles.
    Vidal MDM; Martínez F; Rodríguez I; Polyzos NP
    Hum Reprod; 2024 May; 39(5):1098-1104. PubMed ID: 38498835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of blastocyst euploidy rates following luteal versus follicular phase stimulation in a GnRH antagonist protocol: a prospective study with repeated ovarian stimulation cycles.
    Martinez F; Clua E; Roca M; Garcia S; Polyzos NP
    Hum Reprod; 2022 Nov; 37(12):2777-2786. PubMed ID: 36269092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cumulative live birth rates between progestin-primed ovarian stimulation protocol and gonadotropin-releasing hormone antagonist protocol in different populations.
    Zhou R; Dong M; Huang L; Wang S; Fan L; Liang X; Zhang X; Liu F
    Front Endocrinol (Lausanne); 2023; 14():1117513. PubMed ID: 37143731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestin Primed Ovarian Stimulation (PPOS) protocol yields lower euploidy rate in older patients undergoing IVF.
    Pai AH; Sung YJ; Li CJ; Lin CY; Chang CL
    Reprod Biol Endocrinol; 2023 Aug; 21(1):72. PubMed ID: 37550681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leave the past behind: women's reproductive history shows no association with blastocysts' euploidy and limited association with live birth rates after euploid embryo transfers.
    Cimadomo D; Capalbo A; Dovere L; Tacconi L; Soscia D; Giancani A; Scepi E; Maggiulli R; Vaiarelli A; Rienzi L; Ubaldi FM
    Hum Reprod; 2021 Mar; 36(4):929-940. PubMed ID: 33608730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
    Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
    Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oocyte competence is comparable between progestin primed ovarian stimulation with Norethisterone acetate (NETA-PPOS) and GnRH-antagonist protocols: A matched case-control study in PGT-A cycles.
    Vaiarelli A; Cimadomo D; Ruffa A; Rania E; Pittana E; Gallo C; Fiorenza A; Alviggi E; Alfano S; Carmelo R; Trabucco E; Alviggi C; Rosaria Campitiello M; Rienzi L; Maria Ubaldi F; Venturella R
    Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():4-10. PubMed ID: 38171151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The euploid blastocysts obtained after luteal phase stimulation show the same clinical, obstetric and perinatal outcomes as follicular phase stimulation-derived ones: a multicenter study.
    Vaiarelli A; Cimadomo D; Alviggi E; Sansone A; Trabucco E; Dusi L; Buffo L; Barnocchi N; Fiorini F; Colamaria S; Giuliani M; Argento C; Rienzi L; Ubaldi FM
    Hum Reprod; 2020 Nov; 35(11):2598-2608. PubMed ID: 32951051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteal phase anovulatory follicles result in the production of competent oocytes: intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycle.
    Cimadomo D; Vaiarelli A; Colamaria S; Trabucco E; Alviggi C; Venturella R; Alviggi E; Carmelo R; Rienzi L; Ubaldi FM
    Hum Reprod; 2018 Aug; 33(8):1442-1448. PubMed ID: 29912374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between controlled ovarian stimulation protocols and euploid blastocyst rate in pre-implantation genetic testing for aneuploidy cycles.
    Huang B; Li H; Xu B; Li N; Wang X; Li Y; Zhao J
    Reprod Biol Endocrinol; 2023 Dec; 21(1):118. PubMed ID: 38057895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle.
    Kalafat E; Turkgeldi E; Yıldız S; Dizdar M; Keles I; Ata B
    Front Endocrinol (Lausanne); 2022; 13():837880. PubMed ID: 35663329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No effect of ovarian stimulation and oocyte yield on euploidy and live birth rates: an analysis of 12 298 trophectoderm biopsies.
    Irani M; Canon C; Robles A; Maddy B; Gunnala V; Qin X; Zhang C; Xu K; Rosenwaks Z
    Hum Reprod; 2020 May; 35(5):1082-1089. PubMed ID: 32348476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First PGT-A using human in vivo blastocysts recovered by uterine lavage: comparison with matched IVF embryo controls†.
    Munné S; Nakajima ST; Najmabadi S; Sauer MV; Angle MJ; Rivas JL; Mendieta LV; Macaso TM; Sawarkar S; Nadal A; Choudhary K; Nezhat C; Carson SA; Buster JE
    Hum Reprod; 2020 Jan; 35(1):70-80. PubMed ID: 31886877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of euploidy rates in preimplantation genetic testing for aneuploidy cycles with progestin-primed versus GnRH agonist/antagonist protocol.
    Wang L; Wang J; Zhang Y; Qian C; Wang X; Bai J; Li F; Chen Z; Ai A
    Eur J Med Res; 2023 Jan; 28(1):28. PubMed ID: 36642707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
    Xiao ZN; Peng JL; Yang J; Xu WM
    Curr Med Sci; 2019 Jun; 39(3):431-436. PubMed ID: 31209815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Cumulative Live Birth Rates Between Progestin and GnRH Analogues in Preimplantation Genetic Testing Cycles.
    Zhou R; Dong M; Huang L; Wang S; Wang Z; Xu L; Zhang X; Liu F
    J Clin Endocrinol Metab; 2023 Dec; 109(1):217-226. PubMed ID: 37450562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestin-primed ovarian stimulation versus GnRH antagonist protocol in poor responders: Risk of premature LH surge and outcome of oocyte retrieval.
    Kao TC; Hsieh YC; Yang IJ; Wu MY; Chen MJ; Yang JH; Chen SU
    J Formos Med Assoc; 2023 Jan; 122(1):29-35. PubMed ID: 36123235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance.
    Morin SJ; Patounakis G; Juneau CR; Neal SA; Scott RT; Seli E
    Hum Reprod; 2018 Aug; 33(8):1489-1498. PubMed ID: 30010882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progestin primed ovarian stimulation using corifollitropin alfa in PCOS women effectively prevents LH surge and reduces injection burden compared to GnRH antagonist protocol.
    Huang TC; Huang MZ; Seow KM; Yang IJ; Pan SP; Chen MJ; Hwang JL; Chen SU
    Sci Rep; 2021 Nov; 11(1):22732. PubMed ID: 34815477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.